Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation
Recruiting
Phase 2
Phase 3
Interventional Study
Nasal Bleeding
Nasotracheal Intubation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 70 (estimated)
- Sponsor
- Shaheed Mohtarma Benazir Bhutto Institue of Trauma · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this trial is to compare efficacy of xylometazoline nasal drops and adrenaline nasal pack in participants undergoing elective oromaxillofacial surgeries.
The main question aim to answer is xylometazoline nasal drops better than adrenaline nasal packing in terms of nasal bleeding during nasotracheal intubation. Researchers are comparing 2 groups of participants.
Participants in group …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ASA 1 and 2
* Age group between 18-60 years
* Mallampati score 1 and 2
* Either gender
* Participants who undergo elective oromaxillofacial surgery
Exclusion Criteria:
* Lack of consent
* Participants with anticipated difficult airway
* Participants receiving anticoagulant t…
Contacts
Dr Sidra Javed Consultant Anaesthetist, MBBS, FCPS, PAIN FELLOW
+92333 2474831
CONTACT
Dr Mirza Shahzad Baig Consultant Anaesthetist, MBBS, MCPS, FCPS
+923346441539
CONTACT